Aurinia Pharmaceuticals Inc., of Victoria, British Columbia, said it completed its at-the-market sale of approximately 4.6 million common shares at a weighted average price of $6.55 apiece to raise gross proceeds of approximately $30 million. Jefferies LLC managed the open market sale agreement. On Wednesday, Aurinia's shares (NASDAQ:AUPH) gained 10 cents to close at $7.10.